Daniel Polsky

From Locked Out to Opting in: How the Cures Act Reshaped Medicare Advantage Utilization for Beneficiaries With End‐Stage Kidney Disease

OBJECTIVE: To describe how the characteristics of Medicare Advantage (MA) beneficiaries with end-stage kidney disease (ESKD) changed after the 21st Century Cures Act expanded MA eligibility, and to document accompanying changes in utilization. STUDY SETTING AND DESIGN: The 2021 C...